WHO: Covid-19 antiviral drug molnupiravir recommendation
WHO recommends antiviral drug for patients with non-severe covid-19 at highest risk of hospital admission: The antiviral drug molnupiravir is…
COVID-19
Spike in younger patients looking for cosmetic procedures
New plastic surgeon survey shows a spike in the number of patients looking for cosmetic procedures. Aesthetics have always been…
New Bupa research finds rise in extreme diets
Extreme diets! Bupa’s new research has found more people than ever before are searching for extreme post-pandemic crash diets to…
Long Covid breathing device
Handheld breathing device could reduce breathlessness and improve physical fitness in long COVID patients: New research presented at The Physiological Society's Long…
Covid protection for vulnerable communities in Zimbabwe
Covid prevention campaign launched for vulnerable communities in Zimbabwe: A public health expert at the University of Wolverhampton is working…
The USA’s 2022 fentanyl epidemic
The USA's 2022 Fentanyl Epidemic: Headlines have been full of reports on COVID-related fatalities, but there’s something as contagious that’s…
WHO vaccine hub recipients
WHO announces first technology recipients of mRNA vaccine hub with strong support from African and European partners: At the European…
Coronavirus booster vaccination also protects cancer patients
Coronavirus booster vaccination also protects cancer patients: People with cancer are often given immunosuppressive treatments that weaken their innate immune…
WHO: essential health services face continued disruption during COVID-19 pandemic
Two years into the pandemic, health systems are still facing significant challenges in providing essential health services. Ongoing disruptions have…
COVID-19 human challenge study
Findings from the UK’s world-leading human challenge study provide new insights into mild infections with SARS-CoV-2 in healthy young adults.…